Explicit|||139..143||thus||1|thus|||Contingency.Cause|||||||||||0..137|0|by way of example only, although less potent than the parent compound 2, the illustrative probe of compound 3 retains potency against btk||||||||144..282|1|the piperazine linker and bodipy fluorophore do not seriously compromise accessibility of the illustrative probe to the enzyme active site|||||||||||||
